FR2218896A1 - - Google Patents

Info

Publication number
FR2218896A1
FR2218896A1 FR7406327A FR7406327A FR2218896A1 FR 2218896 A1 FR2218896 A1 FR 2218896A1 FR 7406327 A FR7406327 A FR 7406327A FR 7406327 A FR7406327 A FR 7406327A FR 2218896 A1 FR2218896 A1 FR 2218896A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7406327A
Other languages
French (fr)
Other versions
FR2218896B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of FR2218896A1 publication Critical patent/FR2218896A1/fr
Application granted granted Critical
Publication of FR2218896B1 publication Critical patent/FR2218896B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
FR7406327A 1973-02-26 1974-02-25 Expired FR2218896B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB924973A GB1433774A (en) 1973-02-26 1973-02-26 Heterocyclic compounds apparatus for conveying articles

Publications (2)

Publication Number Publication Date
FR2218896A1 true FR2218896A1 (enExample) 1974-09-20
FR2218896B1 FR2218896B1 (enExample) 1977-09-09

Family

ID=9868317

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7406327A Expired FR2218896B1 (enExample) 1973-02-26 1974-02-25

Country Status (14)

Country Link
JP (1) JPS5029574A (enExample)
AT (1) AT329562B (enExample)
AU (1) AU474797B2 (enExample)
BE (1) BE811246A (enExample)
CA (1) CA1025856A (enExample)
CH (1) CH602707A5 (enExample)
DE (1) DE2407744A1 (enExample)
FR (1) FR2218896B1 (enExample)
GB (1) GB1433774A (enExample)
IE (1) IE38886B1 (enExample)
LU (1) LU69479A1 (enExample)
NL (1) NL7402613A (enExample)
SE (1) SE7401984L (enExample)
ZA (1) ZA74883B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2324304A2 (fr) * 1975-09-22 1977-04-15 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2537140A1 (fr) * 1982-12-07 1984-06-08 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186201A (en) 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4264604A (en) 1977-07-01 1981-04-28 Ciba-Geigy Corporation Quinolonecarboxylic acid derivatives as bactericides
US4390541A (en) 1980-12-19 1983-06-28 Lilly Industries Limited Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease
US4377579A (en) 1981-12-03 1983-03-22 Minnesota Mining And Manufacturing Company N-(Tetrazol-5-yl)phenazine-1-carboxamides
KR960004827B1 (ko) * 1987-01-20 1996-04-16 다이닛뽄 세이야꾸 가부시끼가이샤 헤테로아릴카르복시아미드 유도체, 그의 제조방법 및 그것을 함유하는 의약조성물
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
US6143760A (en) 1997-08-25 2000-11-07 Neurogen Corporation Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
KR20010023313A (ko) * 1997-08-25 2001-03-26 해피 페너 ; 해리 에이치. 페너 2세 Ｇａｂａ 뇌 수용체 리간드로서의 치환된4-옥소-나프티리딘-3-카르복스아미드
EP1056724B1 (en) * 1998-02-26 2005-05-25 Neurogen Corporation Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
DK1503759T3 (da) * 2002-05-14 2009-04-14 Univ California Substituerede quinoloncarboxylsyrer, deres derivater, virkningssted og anvendelser heraf
WO2005009971A1 (ja) * 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
EP2502911B1 (en) * 2004-06-24 2017-04-05 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
RU2528046C2 (ru) * 2004-06-24 2014-09-10 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы транспортеров атф-связывающей кассеты
LT2502911T (lt) 2004-06-24 2017-09-11 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
SI2408750T1 (sl) 2009-03-20 2015-11-30 Vertex Pharmaceuticals Incorporated Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2819670A1 (en) 2012-02-27 2015-01-07 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
WO2013129622A1 (ja) 2012-03-02 2013-09-06 武田薬品工業株式会社 複素環化合物およびその用途
EP2921480B1 (en) 2012-11-19 2017-10-11 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
KR20170063954A (ko) 2014-10-07 2017-06-08 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
CN105330602B (zh) * 2015-12-07 2018-02-09 江南大学 一种癸氧喹酯类似物及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU67918A1 (enExample) * 1972-07-03 1973-09-05

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU67918A1 (enExample) * 1972-07-03 1973-09-05

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2324304A2 (fr) * 1975-09-22 1977-04-15 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2537140A1 (fr) * 1982-12-07 1984-06-08 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant

Also Published As

Publication number Publication date
DE2407744A1 (de) 1974-08-29
JPS5029574A (enExample) 1975-03-25
SE7401984L (enExample) 1974-08-27
IE38886B1 (en) 1978-06-21
AU474797B2 (en) 1976-08-05
AU6559274A (en) 1975-08-14
CH602707A5 (enExample) 1978-07-31
IE38886L (en) 1974-08-26
NL7402613A (enExample) 1974-08-28
GB1433774A (en) 1976-04-28
ATA149974A (de) 1975-08-15
ZA74883B (en) 1974-12-24
CA1025856A (en) 1978-02-07
AT329562B (de) 1976-05-25
FR2218896B1 (enExample) 1977-09-09
BE811246A (fr) 1974-08-19
LU69479A1 (enExample) 1975-05-21

Similar Documents

Publication Publication Date Title
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
FR2218896B1 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AR201229Q (enExample)
AR199451A1 (enExample)
AR196382A1 (enExample)
AR200885A1 (enExample)
AR195948A1 (enExample)
AU447540B2 (enExample)
AU461342B2 (enExample)
AR197627A1 (enExample)
AR200256A1 (enExample)
AR196123Q (enExample)
AR196212Q (enExample)
AU1891376A (enExample)
CH563892A5 (enExample)
BG19320A1 (enExample)
CH565030A5 (enExample)
CH565050A5 (enExample)
CH563008A5 (enExample)
CH566195A5 (enExample)
CH566591A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse